| Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials G Ronco, J Dillner, KM Elfström, S Tunesi, PJF Snijders, M Arbyn, ... The lancet 383 (9916), 524-532, 2014 | 1866 | 2014 |
| Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis GM Clifford, S Gallus, R Herrero, N Munoz, PJF Snijders, S Vaccarella, ... The Lancet 366 (9490), 991-998, 2005 | 1569 | 2005 |
| Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini, P Dalla Palma, ... The lancet oncology 11 (3), 249-257, 2010 | 1178 | 2010 |
| Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer M Arbyn, G Ronco, A Anttila, CJLM Meijer, M Poljak, G Ogilvie, ... Vaccine 30, F88-F99, 2012 | 965 | 2012 |
| Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries J Cuzick, M Arbyn, R Sankaranarayanan, V Tsu, G Ronco, MH Mayrand, ... Vaccine 26, K29-K41, 2008 | 906 | 2008 |
| Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older CJLM Meijer, J Berkhof, PE Castle, AT Hesselink, EL Franco, G Ronco, ... International journal of cancer 124 (3), 516-520, 2009 | 846 | 2009 |
| European guidelines for quality assurance in cervical cancer screening. —summary document M Arbyn, A Anttila, J Jordan, G Ronco, U Schenck, N Segnan, H Wiener, ... Annals of Oncology 21 (3), 448-458, 2010 | 796 | 2010 |
| Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide S Franceschi, R Herrero, GM Clifford, PJF Snijders, A Arslan, PTH Anh, ... International journal of cancer 119 (11), 2677-2684, 2006 | 585 | 2006 |
| Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial G Ronco, N Segnan, P Giorgi-Rossi, M Zappa, GP Casadei, F Carozzi, ... Journal of the National Cancer Institute 98 (11), 765-774, 2006 | 421 | 2006 |
| Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial G Ronco, J Cuzick, P Pierotti, MP Cariaggi, P Dalla Palma, C Naldoni, ... Bmj 335 (7609), 28, 2007 | 397 | 2007 |
| Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini, PD Palma, A Del Mistro, ... Journal of the National Cancer Institute 100 (7), 492-501, 2008 | 376 | 2008 |
| EUROGIN 2011 roadmap on prevention and treatment of HPV‐related disease M Arbyn, S De Sanjosé, M Saraiya, M Sideri, J Palefsky, C Lacey, ... International journal of cancer 131 (9), 1969-1982, 2012 | 324 | 2012 |
| Cervical cancer screening programmes and policies in 18 European countries A Anttila, G Ronco, G Clifford, F Bray, M Hakama, M Arbyn, E Weiderpass British journal of cancer 91 (5), 935-941, 2004 | 319 | 2004 |
| Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial G Ronco, P Giorgi-Rossi, F Carozzi, P Dalla Palma, A Del Mistro, ... The Lancet Oncology 7 (7), 547-555, 2006 | 302 | 2006 |
| European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination L von Karsa, M Arbyn, H De Vuyst, J Dillner, L Dillner, S Franceschi, ... Papillomavirus Research 1, 22-31, 2015 | 287 | 2015 |
| Cervical cancer screening policies and coverage in Europe A Anttila, L von Karsa, A Aasmaa, M Fender, J Patnick, M Rebolj, F Nicula, ... European Journal of Cancer 45 (15), 2649-2658, 2009 | 258 | 2009 |
| Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial F Carozzi, M Confortini, P Dalla Palma, A Del Mistro, A Gillio-Tos, ... The lancet oncology 9 (10), 937-945, 2008 | 257 | 2008 |
| Status of implementation and organization of cancer screening in The European Union Member States—Summary results from the second European screening report P Basu, A Ponti, A Anttila, G Ronco, C Senore, DB Vale, N Segnan, ... International journal of cancer 142 (1), 44-56, 2018 | 235 | 2018 |
| HPV-FASTER: broadening the scope for prevention of HPV-related cancer FX Bosch, C Robles, M Diaz, M Arbyn, I Baussano, C Clavel, G Ronco, ... Nature reviews Clinical oncology 13 (2), 119-132, 2016 | 219 | 2016 |
| Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys S Vaccarella, R Herrero, M Dai, PJF Snijders, CJLM Meijer, JO Thomas, ... Cancer Epidemiology Biomarkers & Prevention 15 (11), 2148-2153, 2006 | 207 | 2006 |
